ARCHIVES

NCI Places Hold On Genentech Drug Trials, Citing Disagreement Over Intellectual Property Provisions.

This article is from The Cancer Letter archive.

Vol. 36 No. 09 | March 12, 2010

Download PDF Visit The Full Archive

Related Articles

Federal AIDS Funds Tp $2 Bil.; Term Proposed For NIH Director

October 19, 1990

In Brief: Search Committee Finds Prospects Uncertain About Election, Unwilling To Take Pay Cut

February 22, 1980

Enter The Cancer Letter’s 35th Anniversary Story Contest

July 31, 2009

In Brief: NCI Deputy Director Ihde To Leave Institute; Bynum To Retire; Lewis Thomas Dead At 80

December 10, 1993

DCT Advisers Ok Expansion of Phase 1, Phase 2 Testing

July 10, 1992

New Core Gant Guideline Proposals Drawn Up; Opposition Developing Among Center Directors

April 4, 1980